Search results for

The 55-year-old Muslim Youth Camp is taking on new meaning as a temporary respite for today's new generation in the current political climate.

How did one of the fastest growing churches in the country find success, and then fall apart so quickly?

President Biden heads to Japan for the G7 summit. An appeals court case could remove abortion pills from the U.S. market completely. Ukraine says it's made advances in the battle for Bakhmut.

Iran and Iranian-backed militias fired missiles at Israel and Arab states, apparently hitting the U.S. Embassy compound in Kuwait, while Israel and the United States pounded targets in Iran on Monday.

The country's top infectious disease doctor says he is looking for "a level of control" over COVID-19 such that it is less disruptive to society — and again stressed the importance of vaccination.

The White House waited to disclose a second meeting between President Trump and Vladimir Putin at the G-20. Also, tensions have increased outside a holy site in Jerusalem following a shooting.

Heated rhetoric continues to define Russia-Ukraine relations. A class-action lawsuit filed against the NFL and three teams alleges racism in hiring practices. Crude oil prices reach seven-year highs.

The Biden administration has delivered a plan to Russia offering a diplomatic way to resolve the crisis over Ukraine. NPR's Ari Shapiro talks with State Dept. spokesman Ned Price about the situation.

Merck documents show that in 2000, the maker of Vioxx tried to censor critics of the drug's safety. That was the year that drug giant Merck learned that Vioxx might cause heart attacks and other problems. The documents show a concerted effort by the company to identify doctors who were raising questions about the drug's safety and to put pressure on them to stop making critical comments. A spokesman for Merck denies the allegations.

Secretary of State Blinken is attending a meeting of southeast Asian nations. Hungary's leader will speak at the CPAC event in Dallas. Democrats may make gains against high prescription drug prices.